GALNT12 |
|||
| MBS8560493-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
GALNT12 |
|||
| MBS8560493-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
GALNT12 |
|||
| MBS8560493-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
GALNT12 |
|||
| MBS8560493-02mL | MyBiosource | 0.2mL | EUR 345 |
GALNT12 Antibody |
|||
| 47372 | SAB | 100ul | EUR 319 |
GALNT12 Antibody |
|||
| 47372-100ul | SAB | 100ul | EUR 302.4 |
GALNT12 Antibody |
|||
| 1-CSB-PA814224LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against GALNT12. Recognizes GALNT12 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
GALNT12 Antibody |
|||
| E047372 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
GALNT12 Antibody |
|||
| E306898 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
GALNT12 Antibody |
|||
| MBS1496941-005mg | MyBiosource | 0.05mg | EUR 190 |
GALNT12 Antibody |
|||
| MBS1496941-01mg | MyBiosource | 0.1mg | EUR 270 |
GALNT12 Antibody |
|||
| MBS1496941-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
GALNT12 Antibody |
|||
| MBS9430354-01mL | MyBiosource | 0.1mL | EUR 305 |
GALNT12 Antibody |
|||
| MBS9430354-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
GALNT12 cDNA Clone |
|||
| MBS1266808-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 200 |
GALNT12 cDNA Clone |
|||
| MBS1266808-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 855 |
Mouse GALNT12 siRNA |
|||
| 20-abx917522 | Abbexa |
|
|
Human GALNT12 siRNA |
|||
| 20-abx917523 | Abbexa |
|
|
GALNT12 siRNA (Human) |
|||
| MBS8227123-15nmol | MyBiosource | 15nmol | EUR 405 |
GALNT12 siRNA (Human) |
|||
| MBS8227123-30nmol | MyBiosource | 30nmol | EUR 565 |
GALNT12 siRNA (Human) |
|||
| MBS8227123-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GALNT12 siRNA (Mouse) |
|||
| MBS8202638-15nmol | MyBiosource | 15nmol | EUR 405 |
GALNT12 siRNA (Mouse) |
|||
| MBS8202638-30nmol | MyBiosource | 30nmol | EUR 565 |
GALNT12 siRNA (Mouse) |
|||
| MBS8202638-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GALNT12 Antibody (HRP) |
|||
| abx308604-100g | Abbexa | 100 µg | EUR 362.5 |
GALNT12 Antibody (HRP) |
|||
| 20-abx308604 | Abbexa |
|
|
GALNT12 Antibody (HRP) |
|||
| abx308604-20g | Abbexa | 20 µg | EUR 162.5 |
GALNT12 Antibody (HRP) |
|||
| abx308604-50g | Abbexa | 50 µg | EUR 250 |
GALNT12 Antibody (FITC) |
|||
| abx308605-100g | Abbexa | 100 µg | EUR 362.5 |
GALNT12 Antibody (FITC) |
|||
| 20-abx308605 | Abbexa |
|
|
GALNT12 Antibody (FITC) |
|||
| abx308605-20g | Abbexa | 20 µg | EUR 162.5 |
GALNT12 Antibody (FITC) |
|||
| abx308605-50g | Abbexa | 50 µg | EUR 250 |
GALNT12 cloning plasmid |
|||
| CSB-CL814224HU-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the GALNT12 gene. |
|||
GALNT12 Antibody (Biotin) |
|||
| abx308606-100g | Abbexa | 100 µg | EUR 362.5 |
GALNT12 Antibody (Biotin) |
|||
| 20-abx308606 | Abbexa |
|
|
GALNT12 Antibody (Biotin) |
|||
| abx308606-20g | Abbexa | 20 µg | EUR 162.5 |
GALNT12 Antibody (Biotin) |
|||
| abx308606-50g | Abbexa | 50 µg | EUR 250 |
GALNT12 Polyclonal Antibody |
|||
| A59194 | EpiGentek |
|
|
GALNT12 Polyclonal Antibody |
|||
| E-AB-18959-120uL | Elabscience Biotech | 120uL | EUR 240 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-18959-200uL | Elabscience Biotech | 200uL | EUR 399 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-18959-20uL | Elabscience Biotech | 20uL | EUR 73 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-18959-60uL | Elabscience Biotech | 60uL | EUR 143 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-52869-120uL | Elabscience Biotech | 120uL | EUR 240 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-52869-200uL | Elabscience Biotech | 200uL | EUR 399 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-52869-20uL | Elabscience Biotech | 20uL | EUR 73 |
|
Description: Unconjugated |
|||
GALNT12 Polyclonal Antibody |
|||
| E-AB-52869-60uL | Elabscience Biotech | 60uL | EUR 143 |
|
Description: Unconjugated |
|||
GALNT12 Conjugated Antibody |
|||
| C47372 | SAB | 100ul | EUR 476.4 |
GALNT12 Polyclonal Antibody |
|||
| MBS2560848-002mL | MyBiosource | 0.02mL | EUR 135 |
GALNT12 Polyclonal Antibody |
|||
| MBS2560848-006mL | MyBiosource | 0.06mL | EUR 190 |
GALNT12 Polyclonal Antibody |
|||
| MBS2560848-012mL | MyBiosource | 0.12mL | EUR 265 |
GALNT12 Polyclonal Antibody |
|||
| MBS2560848-02mL | MyBiosource | 0.2mL | EUR 415 |
GALNT12 Polyclonal Antibody |
|||
| MBS2560848-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
GALNT12 Polyclonal Antibody |
|||
| MBS2562771-002mL | MyBiosource | 0.02mL | EUR 135 |
GALNT12 Polyclonal Antibody |
|||
| MBS2562771-006mL | MyBiosource | 0.06mL | EUR 190 |
GALNT12 Polyclonal Antibody |
|||
| MBS2562771-012mL | MyBiosource | 0.12mL | EUR 265 |
GALNT12 Polyclonal Antibody |
|||
| MBS2562771-02mL | MyBiosource | 0.2mL | EUR 415 |
GALNT12 Polyclonal Antibody |
|||
| MBS2562771-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
GALNT12 Conjugated Antibody |
|||
| MBS9455220-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
GALNT12 Conjugated Antibody |
|||
| MBS9455220-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
GALNT12 Conjugated Antibody |
|||
| MBS9455220-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
GALNT12 Conjugated Antibody |
|||
| MBS9455220-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
GALNT12 Conjugated Antibody |
|||
| MBS9455220-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
GALNT12 Polyclonal Antibody |
|||
| RD252869A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD252869A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD252869A-20uL | Reddot Biotech | 20μL | EUR 109.5 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD252869A-60uL | Reddot Biotech | 60μL | EUR 214.5 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD218959A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD218959A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD218959A-20uL | Reddot Biotech | 20μL | EUR 109.5 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
GALNT12 Polyclonal Antibody |
|||
| RD218959A-60uL | Reddot Biotech | 60μL | EUR 214.5 |
|
Description: This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
|||
